StockWatch
·
Pharmaceuticals
ESG13 Jul 2026, 08:50 pm

Lupin Ltd Files FY26 Business Responsibility and Sustainability Report

AI Summary

Lupin Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. This report, which is part of the Integrated Report 2025-26, details the company's commitment to environmental, social, and governance (ESG) principles. The filing includes comprehensive information on Lupin's corporate identity, business activities contributing to 98.4% of turnover through pharmaceutical manufacturing, and its extensive operational footprint across 17 national and 10 international locations. The report also highlights the company's market reach, serving 28 states and 6 Union Territories in India and 136 countries internationally, with exports accounting for 58.6% of its total turnover of INR 190,444.2 million. Employee details and a focus on talent development are also covered.

Key Highlights

  • Lupin Ltd filed its FY26 Business Responsibility and Sustainability Report.
  • Pharmaceutical manufacturing accounts for 98.4% of turnover.
  • Exports represent 58.6% of total turnover.
  • Company operates across 17 national and 10 international locations.
  • Report details ESG commitments and operational scope.